CA2074816A1 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
CA2074816A1
CA2074816A1 CA002074816A CA2074816A CA2074816A1 CA 2074816 A1 CA2074816 A1 CA 2074816A1 CA 002074816 A CA002074816 A CA 002074816A CA 2074816 A CA2074816 A CA 2074816A CA 2074816 A1 CA2074816 A1 CA 2074816A1
Authority
CA
Canada
Prior art keywords
formula
compound
benzopyrano
pyrazol
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002074816A
Other languages
English (en)
French (fr)
Inventor
Roger B. Titman
Michael H. Hockley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2074816A1 publication Critical patent/CA2074816A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002074816A 1990-02-06 1991-01-26 Therapeutic agents Abandoned CA2074816A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9002423.3 1990-02-06
GB909002423A GB9002423D0 (en) 1990-02-06 1990-02-06 Therapeutic agents

Publications (1)

Publication Number Publication Date
CA2074816A1 true CA2074816A1 (en) 1991-08-07

Family

ID=10670368

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002074816A Abandoned CA2074816A1 (en) 1990-02-06 1991-01-26 Therapeutic agents

Country Status (16)

Country Link
JP (1) JPH05504141A (enrdf_load_stackoverflow)
KR (1) KR927003600A (enrdf_load_stackoverflow)
AU (1) AU7187791A (enrdf_load_stackoverflow)
BR (1) BR9105990A (enrdf_load_stackoverflow)
CA (1) CA2074816A1 (enrdf_load_stackoverflow)
FI (1) FI923528A0 (enrdf_load_stackoverflow)
GB (1) GB9002423D0 (enrdf_load_stackoverflow)
HU (1) HUT63848A (enrdf_load_stackoverflow)
IE (1) IE910287A1 (enrdf_load_stackoverflow)
IL (1) IL97109A0 (enrdf_load_stackoverflow)
IN (1) IN172129B (enrdf_load_stackoverflow)
MX (1) MX24407A (enrdf_load_stackoverflow)
NO (1) NO923082D0 (enrdf_load_stackoverflow)
PT (1) PT96687A (enrdf_load_stackoverflow)
WO (1) WO1991012255A1 (enrdf_load_stackoverflow)
ZA (1) ZA91833B (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9116241D0 (en) * 1991-07-27 1991-09-11 Boots Co Plc Therapeutic agents
EP1813616B1 (en) * 2002-11-22 2013-03-27 Active Biotech AB Pyrazoloquinolines with immunomodulating activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA895646B (en) * 1988-08-09 1990-04-25 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
IN172129B (enrdf_load_stackoverflow) 1993-04-10
HUT63848A (en) 1993-10-28
PT96687A (pt) 1991-10-31
NO923082L (no) 1992-08-05
BR9105990A (pt) 1992-11-10
MX24407A (es) 1993-10-01
FI923528L (fi) 1992-08-05
IE910287A1 (en) 1991-08-14
WO1991012255A1 (en) 1991-08-22
AU7187791A (en) 1991-09-03
KR927003600A (ko) 1992-12-18
IL97109A0 (en) 1992-03-29
GB9002423D0 (en) 1990-04-04
NO923082D0 (no) 1992-08-05
HU9202540D0 (en) 1992-10-28
FI923528A7 (fi) 1992-08-05
JPH05504141A (ja) 1993-07-01
ZA91833B (en) 1991-10-30
FI923528A0 (fi) 1992-08-05

Similar Documents

Publication Publication Date Title
US7514441B2 (en) Substituted pyrazolo [1,5-A]pyrimidines as calcium receptor modulating agents
JP5680624B2 (ja) ７−アザ−スピロ［３．５］ノナン−７−カルボン酸エステル誘導体、これらの調製およびこれらの治療用途
JP3270830B2 (ja) 化合物
US20060004055A1 (en) Derivative of 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(piperidine-1-yl)-1H-pyrazole-3-carboxamide, the preparation and therapeutic use thereof
JPH07324076A (ja) 新規なピラゾール−３−カルボキサミド誘導体、これらを製造するための方法及びこれらが存在する薬学的組成物
JP2008525404A (ja) 治療剤
JP2672312B2 (ja) ヘテロアリール３‐オキソ‐プロバンニトリル誘導体及びその製造方法
CA1246563A (en) 3-arylcarbonyl- and 3-cycloalkylcarbonyl-1-aminoalkyl- 1h-indoles useful as analgesics
CS248035B2 (en) Production method of the(4(oxo-4h)1(-benzopyran-8-yl)carboxyle acides
FR2882054A1 (fr) Derives de 1,5-diarylpyrrole, leur preparation et leur application en therapeutique
JPH035481A (ja) ピリダジノン誘導体
NO802326L (no) Fremgangsmaate ved fremstilling av substituerte tetraazatricyklen
CN102260253B (zh) 苯并[5,6]环庚基[1,2-b]吡啶衍生物、制备方法、药物组合物及其抗过敏性疾病的用途
CA2074816A1 (en) Therapeutic agents
US5075317A (en) Spirofurane derivatives
WO1990001481A1 (en) Therapeutic agents
CA2074841A1 (en) Therapeutic agents
JPH06199855A (ja) ピラゾロピリジン誘導体及びこれを含有する血小板凝集抑制剤
GB2089792A (en) Substituted benzopyranotriazoles
FR2593179A1 (fr) Derives d'imidazo(1,2-a)quinoleines, leur preparation et leur application en therapeutique
AU625915B2 (en) Synthesis of (1)-benzothiopyrano (4,3-c)-pyrazoles
EP0091181B1 (en) Aroyl pyrrolizine compounds, process for their preparation and pharmaceutical compositions containing them
EP0284018B1 (en) Benzopyran[4,3-d]-thiazole-derivatives with anti-allergic, anti-anaphylactic and anti-arthritic activity and compositions containing them
IE922217A1 (en) Therapeutic agents
JPH0378868B2 (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 19940726